• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of CDER advisory committee member positions vacant at the end of the month

Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm

Information is current as of June 30, 2014.

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetPercent Vacant Positions
Oct 20131024
Nov 20131022
Dec 20131022
Jan 20141023
Feb 20141019
Mar 20141019
Apr 20141018
May 20141017
Jun 20141018
Jul 201410TBD
Aug 201410TBD
Sep 201410TBD

FY 2014 YTD: 18%

Number of CDER advisory committee member positions vacant at the end of the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetVacant Positions
Oct 2013N/A62
Nov 2013N/A57
Dec 2013N/A56
Jan 2014N/A58
Feb 2014N/A47
Mar 2014N/A46
Apr 2014N/A43
May 2014N/A41
Jun 2014N/A41
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD:41

Total number of CDER advisory committee member positions at the end of the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetPositions
Oct 2013N/A257
Nov 2013N/A257
Dec 2013N/A257
Jan 2014N/A257
Feb 2014N/A244
Mar 2014N/A242
Apr 2014N/A242
May 2014N/A236
Jun 2014N/A232
Jul 2014N/ATBD
Aug 2014N/ATBD
Sep 2014N/ATBD

FY 2014 YTD: 242

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.